Medical Devices & Consumables
Global Immortalized Human Cells Market Research Report 2026
- Feb 24, 26
- ID: 716460
- Pages: 134
- Figures: 136
- Views: 1
This report delivers a comprehensive overview of the global Immortalized Human Cells market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immortalized Human Cells. The Immortalized Human Cells market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Immortalized Human Cells market comprehensively. Regional market sizes by Type, by Application, by Source, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Immortalized Human Cells manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Ispecimen
ABO Bio
AnaBios
Biomedica Cro
Bioivt
Iprocess
Crown Bioscience
Biomex
PrecisionMed
Cureline
DX Biosamples
Audubon
Precision for Medicine
Discovery Life Sciences
ProteoGenex
CGT Global
Segment by Type
Ready-to-use
Customized
Segment by Source
Liver-Derived
Kidney-Derived
Nervous System-Derived
Other
Segment by Identity
Identified Samples
Anonymized Samples
Segment by Application
Medical Research
Vaccine Development
Gene Therapy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Source, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Immortalized Human Cells companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Immortalized Human Cells market comprehensively. Regional market sizes by Type, by Application, by Source, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Immortalized Human Cells manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Ispecimen
ABO Bio
AnaBios
Biomedica Cro
Bioivt
Iprocess
Crown Bioscience
Biomex
PrecisionMed
Cureline
DX Biosamples
Audubon
Precision for Medicine
Discovery Life Sciences
ProteoGenex
CGT Global
Segment by Type
Ready-to-use
Customized
Segment by Source
Liver-Derived
Kidney-Derived
Nervous System-Derived
Other
Segment by Identity
Identified Samples
Anonymized Samples
Segment by Application
Medical Research
Vaccine Development
Gene Therapy
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Source, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Immortalized Human Cells companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immortalized Human Cells Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Ready-to-use
1.2.3 Customized
1.3 Market by Source
1.3.1 Global Immortalized Human Cells Market Size Growth Rate by Source: 2021 vs 2025 vs 2032
1.3.2 Liver-Derived
1.3.3 Kidney-Derived
1.3.4 Nervous System-Derived
1.3.5 Other
1.4 Market by Identity
1.4.1 Global Immortalized Human Cells Market Size Growth Rate by Identity: 2021 vs 2025 vs 2032
1.4.2 Identified Samples
1.4.3 Anonymized Samples
1.5 Market by Application
1.5.1 Global Immortalized Human Cells Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Medical Research
1.5.3 Vaccine Development
1.5.4 Gene Therapy
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Immortalized Human Cells Market Perspective (2021–2032)
2.2 Global Immortalized Human Cells Growth Trends by Region
2.2.1 Global Immortalized Human Cells Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Immortalized Human Cells Historic Market Size by Region (2021–2026)
2.2.3 Immortalized Human Cells Forecasted Market Size by Region (2027–2032)
2.3 Immortalized Human Cells Market Dynamics
2.3.1 Immortalized Human Cells Industry Trends
2.3.2 Immortalized Human Cells Market Drivers
2.3.3 Immortalized Human Cells Market Challenges
2.3.4 Immortalized Human Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immortalized Human Cells Players by Revenue
3.1.1 Global Top Immortalized Human Cells Players by Revenue (2021–2026)
3.1.2 Global Immortalized Human Cells Revenue Market Share by Players (2021–2026)
3.2 Global Top Immortalized Human Cells Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Immortalized Human Cells Revenue
3.4 Global Immortalized Human Cells Market Concentration Ratio
3.4.1 Global Immortalized Human Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immortalized Human Cells Revenue in 2025
3.5 Global Key Players of Immortalized Human Cells Head Offices and Areas Served
3.6 Global Key Players of Immortalized Human Cells, Products and Applications
3.7 Global Key Players of Immortalized Human Cells, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Immortalized Human Cells Breakdown Data by Type
4.1 Global Immortalized Human Cells Historic Market Size by Type (2021–2026)
4.2 Global Immortalized Human Cells Forecasted Market Size by Type (2027–2032)
5 Immortalized Human Cells Breakdown Data by Application
5.1 Global Immortalized Human Cells Historic Market Size by Application (2021–2026)
5.2 Global Immortalized Human Cells Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Immortalized Human Cells Market Size (2021–2032)
6.2 North America Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Immortalized Human Cells Market Size by Country (2021–2026)
6.4 North America Immortalized Human Cells Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immortalized Human Cells Market Size (2021–2032)
7.2 Europe Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Immortalized Human Cells Market Size by Country (2021–2026)
7.4 Europe Immortalized Human Cells Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Immortalized Human Cells Market Size (2021–2032)
8.2 Asia-Pacific Immortalized Human Cells Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Immortalized Human Cells Market Size by Region (2021–2026)
8.4 Asia-Pacific Immortalized Human Cells Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Immortalized Human Cells Market Size (2021–2032)
9.2 Latin America Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Immortalized Human Cells Market Size by Country (2021–2026)
9.4 Latin America Immortalized Human Cells Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immortalized Human Cells Market Size (2021–2032)
10.2 Middle East & Africa Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Immortalized Human Cells Market Size by Country (2021–2026)
10.4 Middle East & Africa Immortalized Human Cells Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ispecimen
11.1.1 Ispecimen Company Details
11.1.2 Ispecimen Business Overview
11.1.3 Ispecimen Immortalized Human Cells Introduction
11.1.4 Ispecimen Revenue in Immortalized Human Cells Business (2021–2026)
11.1.5 Ispecimen Recent Development
11.2 ABO Bio
11.2.1 ABO Bio Company Details
11.2.2 ABO Bio Business Overview
11.2.3 ABO Bio Immortalized Human Cells Introduction
11.2.4 ABO Bio Revenue in Immortalized Human Cells Business (2021–2026)
11.2.5 ABO Bio Recent Development
11.3 AnaBios
11.3.1 AnaBios Company Details
11.3.2 AnaBios Business Overview
11.3.3 AnaBios Immortalized Human Cells Introduction
11.3.4 AnaBios Revenue in Immortalized Human Cells Business (2021–2026)
11.3.5 AnaBios Recent Development
11.4 Biomedica Cro
11.4.1 Biomedica Cro Company Details
11.4.2 Biomedica Cro Business Overview
11.4.3 Biomedica Cro Immortalized Human Cells Introduction
11.4.4 Biomedica Cro Revenue in Immortalized Human Cells Business (2021–2026)
11.4.5 Biomedica Cro Recent Development
11.5 Bioivt
11.5.1 Bioivt Company Details
11.5.2 Bioivt Business Overview
11.5.3 Bioivt Immortalized Human Cells Introduction
11.5.4 Bioivt Revenue in Immortalized Human Cells Business (2021–2026)
11.5.5 Bioivt Recent Development
11.6 Iprocess
11.6.1 Iprocess Company Details
11.6.2 Iprocess Business Overview
11.6.3 Iprocess Immortalized Human Cells Introduction
11.6.4 Iprocess Revenue in Immortalized Human Cells Business (2021–2026)
11.6.5 Iprocess Recent Development
11.7 Crown Bioscience
11.7.1 Crown Bioscience Company Details
11.7.2 Crown Bioscience Business Overview
11.7.3 Crown Bioscience Immortalized Human Cells Introduction
11.7.4 Crown Bioscience Revenue in Immortalized Human Cells Business (2021–2026)
11.7.5 Crown Bioscience Recent Development
11.8 Biomex
11.8.1 Biomex Company Details
11.8.2 Biomex Business Overview
11.8.3 Biomex Immortalized Human Cells Introduction
11.8.4 Biomex Revenue in Immortalized Human Cells Business (2021–2026)
11.8.5 Biomex Recent Development
11.9 PrecisionMed
11.9.1 PrecisionMed Company Details
11.9.2 PrecisionMed Business Overview
11.9.3 PrecisionMed Immortalized Human Cells Introduction
11.9.4 PrecisionMed Revenue in Immortalized Human Cells Business (2021–2026)
11.9.5 PrecisionMed Recent Development
11.10 Cureline
11.10.1 Cureline Company Details
11.10.2 Cureline Business Overview
11.10.3 Cureline Immortalized Human Cells Introduction
11.10.4 Cureline Revenue in Immortalized Human Cells Business (2021–2026)
11.10.5 Cureline Recent Development
11.11 DX Biosamples
11.11.1 DX Biosamples Company Details
11.11.2 DX Biosamples Business Overview
11.11.3 DX Biosamples Immortalized Human Cells Introduction
11.11.4 DX Biosamples Revenue in Immortalized Human Cells Business (2021–2026)
11.11.5 DX Biosamples Recent Development
11.12 Audubon
11.12.1 Audubon Company Details
11.12.2 Audubon Business Overview
11.12.3 Audubon Immortalized Human Cells Introduction
11.12.4 Audubon Revenue in Immortalized Human Cells Business (2021–2026)
11.12.5 Audubon Recent Development
11.13 Precision for Medicine
11.13.1 Precision for Medicine Company Details
11.13.2 Precision for Medicine Business Overview
11.13.3 Precision for Medicine Immortalized Human Cells Introduction
11.13.4 Precision for Medicine Revenue in Immortalized Human Cells Business (2021–2026)
11.13.5 Precision for Medicine Recent Development
11.14 Discovery Life Sciences
11.14.1 Discovery Life Sciences Company Details
11.14.2 Discovery Life Sciences Business Overview
11.14.3 Discovery Life Sciences Immortalized Human Cells Introduction
11.14.4 Discovery Life Sciences Revenue in Immortalized Human Cells Business (2021–2026)
11.14.5 Discovery Life Sciences Recent Development
11.15 ProteoGenex
11.15.1 ProteoGenex Company Details
11.15.2 ProteoGenex Business Overview
11.15.3 ProteoGenex Immortalized Human Cells Introduction
11.15.4 ProteoGenex Revenue in Immortalized Human Cells Business (2021–2026)
11.15.5 ProteoGenex Recent Development
11.16 CGT Global
11.16.1 CGT Global Company Details
11.16.2 CGT Global Business Overview
11.16.3 CGT Global Immortalized Human Cells Introduction
11.16.4 CGT Global Revenue in Immortalized Human Cells Business (2021–2026)
11.16.5 CGT Global Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immortalized Human Cells Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Ready-to-use
1.2.3 Customized
1.3 Market by Source
1.3.1 Global Immortalized Human Cells Market Size Growth Rate by Source: 2021 vs 2025 vs 2032
1.3.2 Liver-Derived
1.3.3 Kidney-Derived
1.3.4 Nervous System-Derived
1.3.5 Other
1.4 Market by Identity
1.4.1 Global Immortalized Human Cells Market Size Growth Rate by Identity: 2021 vs 2025 vs 2032
1.4.2 Identified Samples
1.4.3 Anonymized Samples
1.5 Market by Application
1.5.1 Global Immortalized Human Cells Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Medical Research
1.5.3 Vaccine Development
1.5.4 Gene Therapy
1.5.5 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Immortalized Human Cells Market Perspective (2021–2032)
2.2 Global Immortalized Human Cells Growth Trends by Region
2.2.1 Global Immortalized Human Cells Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Immortalized Human Cells Historic Market Size by Region (2021–2026)
2.2.3 Immortalized Human Cells Forecasted Market Size by Region (2027–2032)
2.3 Immortalized Human Cells Market Dynamics
2.3.1 Immortalized Human Cells Industry Trends
2.3.2 Immortalized Human Cells Market Drivers
2.3.3 Immortalized Human Cells Market Challenges
2.3.4 Immortalized Human Cells Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immortalized Human Cells Players by Revenue
3.1.1 Global Top Immortalized Human Cells Players by Revenue (2021–2026)
3.1.2 Global Immortalized Human Cells Revenue Market Share by Players (2021–2026)
3.2 Global Top Immortalized Human Cells Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Immortalized Human Cells Revenue
3.4 Global Immortalized Human Cells Market Concentration Ratio
3.4.1 Global Immortalized Human Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immortalized Human Cells Revenue in 2025
3.5 Global Key Players of Immortalized Human Cells Head Offices and Areas Served
3.6 Global Key Players of Immortalized Human Cells, Products and Applications
3.7 Global Key Players of Immortalized Human Cells, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Immortalized Human Cells Breakdown Data by Type
4.1 Global Immortalized Human Cells Historic Market Size by Type (2021–2026)
4.2 Global Immortalized Human Cells Forecasted Market Size by Type (2027–2032)
5 Immortalized Human Cells Breakdown Data by Application
5.1 Global Immortalized Human Cells Historic Market Size by Application (2021–2026)
5.2 Global Immortalized Human Cells Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Immortalized Human Cells Market Size (2021–2032)
6.2 North America Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Immortalized Human Cells Market Size by Country (2021–2026)
6.4 North America Immortalized Human Cells Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immortalized Human Cells Market Size (2021–2032)
7.2 Europe Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Immortalized Human Cells Market Size by Country (2021–2026)
7.4 Europe Immortalized Human Cells Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Immortalized Human Cells Market Size (2021–2032)
8.2 Asia-Pacific Immortalized Human Cells Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Immortalized Human Cells Market Size by Region (2021–2026)
8.4 Asia-Pacific Immortalized Human Cells Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Immortalized Human Cells Market Size (2021–2032)
9.2 Latin America Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Immortalized Human Cells Market Size by Country (2021–2026)
9.4 Latin America Immortalized Human Cells Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immortalized Human Cells Market Size (2021–2032)
10.2 Middle East & Africa Immortalized Human Cells Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Immortalized Human Cells Market Size by Country (2021–2026)
10.4 Middle East & Africa Immortalized Human Cells Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ispecimen
11.1.1 Ispecimen Company Details
11.1.2 Ispecimen Business Overview
11.1.3 Ispecimen Immortalized Human Cells Introduction
11.1.4 Ispecimen Revenue in Immortalized Human Cells Business (2021–2026)
11.1.5 Ispecimen Recent Development
11.2 ABO Bio
11.2.1 ABO Bio Company Details
11.2.2 ABO Bio Business Overview
11.2.3 ABO Bio Immortalized Human Cells Introduction
11.2.4 ABO Bio Revenue in Immortalized Human Cells Business (2021–2026)
11.2.5 ABO Bio Recent Development
11.3 AnaBios
11.3.1 AnaBios Company Details
11.3.2 AnaBios Business Overview
11.3.3 AnaBios Immortalized Human Cells Introduction
11.3.4 AnaBios Revenue in Immortalized Human Cells Business (2021–2026)
11.3.5 AnaBios Recent Development
11.4 Biomedica Cro
11.4.1 Biomedica Cro Company Details
11.4.2 Biomedica Cro Business Overview
11.4.3 Biomedica Cro Immortalized Human Cells Introduction
11.4.4 Biomedica Cro Revenue in Immortalized Human Cells Business (2021–2026)
11.4.5 Biomedica Cro Recent Development
11.5 Bioivt
11.5.1 Bioivt Company Details
11.5.2 Bioivt Business Overview
11.5.3 Bioivt Immortalized Human Cells Introduction
11.5.4 Bioivt Revenue in Immortalized Human Cells Business (2021–2026)
11.5.5 Bioivt Recent Development
11.6 Iprocess
11.6.1 Iprocess Company Details
11.6.2 Iprocess Business Overview
11.6.3 Iprocess Immortalized Human Cells Introduction
11.6.4 Iprocess Revenue in Immortalized Human Cells Business (2021–2026)
11.6.5 Iprocess Recent Development
11.7 Crown Bioscience
11.7.1 Crown Bioscience Company Details
11.7.2 Crown Bioscience Business Overview
11.7.3 Crown Bioscience Immortalized Human Cells Introduction
11.7.4 Crown Bioscience Revenue in Immortalized Human Cells Business (2021–2026)
11.7.5 Crown Bioscience Recent Development
11.8 Biomex
11.8.1 Biomex Company Details
11.8.2 Biomex Business Overview
11.8.3 Biomex Immortalized Human Cells Introduction
11.8.4 Biomex Revenue in Immortalized Human Cells Business (2021–2026)
11.8.5 Biomex Recent Development
11.9 PrecisionMed
11.9.1 PrecisionMed Company Details
11.9.2 PrecisionMed Business Overview
11.9.3 PrecisionMed Immortalized Human Cells Introduction
11.9.4 PrecisionMed Revenue in Immortalized Human Cells Business (2021–2026)
11.9.5 PrecisionMed Recent Development
11.10 Cureline
11.10.1 Cureline Company Details
11.10.2 Cureline Business Overview
11.10.3 Cureline Immortalized Human Cells Introduction
11.10.4 Cureline Revenue in Immortalized Human Cells Business (2021–2026)
11.10.5 Cureline Recent Development
11.11 DX Biosamples
11.11.1 DX Biosamples Company Details
11.11.2 DX Biosamples Business Overview
11.11.3 DX Biosamples Immortalized Human Cells Introduction
11.11.4 DX Biosamples Revenue in Immortalized Human Cells Business (2021–2026)
11.11.5 DX Biosamples Recent Development
11.12 Audubon
11.12.1 Audubon Company Details
11.12.2 Audubon Business Overview
11.12.3 Audubon Immortalized Human Cells Introduction
11.12.4 Audubon Revenue in Immortalized Human Cells Business (2021–2026)
11.12.5 Audubon Recent Development
11.13 Precision for Medicine
11.13.1 Precision for Medicine Company Details
11.13.2 Precision for Medicine Business Overview
11.13.3 Precision for Medicine Immortalized Human Cells Introduction
11.13.4 Precision for Medicine Revenue in Immortalized Human Cells Business (2021–2026)
11.13.5 Precision for Medicine Recent Development
11.14 Discovery Life Sciences
11.14.1 Discovery Life Sciences Company Details
11.14.2 Discovery Life Sciences Business Overview
11.14.3 Discovery Life Sciences Immortalized Human Cells Introduction
11.14.4 Discovery Life Sciences Revenue in Immortalized Human Cells Business (2021–2026)
11.14.5 Discovery Life Sciences Recent Development
11.15 ProteoGenex
11.15.1 ProteoGenex Company Details
11.15.2 ProteoGenex Business Overview
11.15.3 ProteoGenex Immortalized Human Cells Introduction
11.15.4 ProteoGenex Revenue in Immortalized Human Cells Business (2021–2026)
11.15.5 ProteoGenex Recent Development
11.16 CGT Global
11.16.1 CGT Global Company Details
11.16.2 CGT Global Business Overview
11.16.3 CGT Global Immortalized Human Cells Introduction
11.16.4 CGT Global Revenue in Immortalized Human Cells Business (2021–2026)
11.16.5 CGT Global Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Immortalized Human Cells Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Ready-to-use
Table 3. Key Players of Customized
Table 4. Global Immortalized Human Cells Market Size Growth Rate by Source (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Liver-Derived
Table 6. Key Players of Kidney-Derived
Table 7. Key Players of Nervous System-Derived
Table 8. Key Players of Other
Table 9. Global Immortalized Human Cells Market Size Growth Rate by Identity (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Identified Samples
Table 11. Key Players of Anonymized Samples
Table 12. Global Immortalized Human Cells Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 13. Global Immortalized Human Cells Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Immortalized Human Cells Market Size by Region (US$ Million), 2021–2026
Table 15. Global Immortalized Human Cells Market Share by Region (2021–2026)
Table 16. Global Immortalized Human Cells Forecasted Market Size by Region (US$ Million), 2027–2032
Table 17. Global Immortalized Human Cells Market Share by Region (2027–2032)
Table 18. Immortalized Human Cells Market Trends
Table 19. Immortalized Human Cells Market Drivers
Table 20. Immortalized Human Cells Market Challenges
Table 21. Immortalized Human Cells Market Restraints
Table 22. Global Immortalized Human Cells Revenue by Players (US$ Million), 2021–2026
Table 23. Global Immortalized Human Cells Market Share by Players (2021–2026)
Table 24. Global Top Immortalized Human Cells Players by Tier (Tier 1, Tier 2, and Tier 3), based on Immortalized Human Cells Revenue, 2025
Table 25. Ranking of Global Top Immortalized Human Cells Companies by Revenue (US$ Million) in 2025
Table 26. Global 5 Largest Players Market Share by Immortalized Human Cells Revenue (CR5 and HHI), 2021–2026
Table 27. Global Key Players of Immortalized Human Cells, Headquarters and Area Served
Table 28. Global Key Players of Immortalized Human Cells, Products and Applications
Table 29. Global Key Players of Immortalized Human Cells, Date of General Availability (GA)
Table 30. Mergers and Acquisitions, Expansion Plans
Table 31. Global Immortalized Human Cells Market Size by Type (US$ Million), 2021–2026
Table 32. Global Immortalized Human Cells Revenue Market Share by Type (2021–2026)
Table 33. Global Immortalized Human Cells Forecasted Market Size by Type (US$ Million), 2027–2032
Table 34. Global Immortalized Human Cells Revenue Market Share by Type (2027–2032)
Table 35. Global Immortalized Human Cells Market Size by Application (US$ Million), 2021–2026
Table 36. Global Immortalized Human Cells Revenue Market Share by Application (2021–2026)
Table 37. Global Immortalized Human Cells Forecasted Market Size by Application (US$ Million), 2027–2032
Table 38. Global Immortalized Human Cells Revenue Market Share by Application (2027–2032)
Table 39. North America Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 40. North America Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026
Table 41. North America Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032
Table 42. Europe Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Europe Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026
Table 44. Europe Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032
Table 45. Asia-Pacific Immortalized Human Cells Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 46. Asia-Pacific Immortalized Human Cells Market Size by Region (US$ Million), 2021–2026
Table 47. Asia-Pacific Immortalized Human Cells Market Size by Region (US$ Million), 2027–2032
Table 48. Latin America Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Latin America Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026
Table 50. Latin America Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032
Table 51. Middle East & Africa Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Middle East & Africa Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026
Table 53. Middle East & Africa Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032
Table 54. Ispecimen Company Details
Table 55. Ispecimen Business Overview
Table 56. Ispecimen Immortalized Human Cells Product
Table 57. Ispecimen Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 58. Ispecimen Recent Development
Table 59. ABO Bio Company Details
Table 60. ABO Bio Business Overview
Table 61. ABO Bio Immortalized Human Cells Product
Table 62. ABO Bio Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 63. ABO Bio Recent Development
Table 64. AnaBios Company Details
Table 65. AnaBios Business Overview
Table 66. AnaBios Immortalized Human Cells Product
Table 67. AnaBios Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 68. AnaBios Recent Development
Table 69. Biomedica Cro Company Details
Table 70. Biomedica Cro Business Overview
Table 71. Biomedica Cro Immortalized Human Cells Product
Table 72. Biomedica Cro Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 73. Biomedica Cro Recent Development
Table 74. Bioivt Company Details
Table 75. Bioivt Business Overview
Table 76. Bioivt Immortalized Human Cells Product
Table 77. Bioivt Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 78. Bioivt Recent Development
Table 79. Iprocess Company Details
Table 80. Iprocess Business Overview
Table 81. Iprocess Immortalized Human Cells Product
Table 82. Iprocess Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 83. Iprocess Recent Development
Table 84. Crown Bioscience Company Details
Table 85. Crown Bioscience Business Overview
Table 86. Crown Bioscience Immortalized Human Cells Product
Table 87. Crown Bioscience Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 88. Crown Bioscience Recent Development
Table 89. Biomex Company Details
Table 90. Biomex Business Overview
Table 91. Biomex Immortalized Human Cells Product
Table 92. Biomex Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 93. Biomex Recent Development
Table 94. PrecisionMed Company Details
Table 95. PrecisionMed Business Overview
Table 96. PrecisionMed Immortalized Human Cells Product
Table 97. PrecisionMed Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 98. PrecisionMed Recent Development
Table 99. Cureline Company Details
Table 100. Cureline Business Overview
Table 101. Cureline Immortalized Human Cells Product
Table 102. Cureline Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 103. Cureline Recent Development
Table 104. DX Biosamples Company Details
Table 105. DX Biosamples Business Overview
Table 106. DX Biosamples Immortalized Human Cells Product
Table 107. DX Biosamples Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 108. DX Biosamples Recent Development
Table 109. Audubon Company Details
Table 110. Audubon Business Overview
Table 111. Audubon Immortalized Human Cells Product
Table 112. Audubon Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 113. Audubon Recent Development
Table 114. Precision for Medicine Company Details
Table 115. Precision for Medicine Business Overview
Table 116. Precision for Medicine Immortalized Human Cells Product
Table 117. Precision for Medicine Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 118. Precision for Medicine Recent Development
Table 119. Discovery Life Sciences Company Details
Table 120. Discovery Life Sciences Business Overview
Table 121. Discovery Life Sciences Immortalized Human Cells Product
Table 122. Discovery Life Sciences Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 123. Discovery Life Sciences Recent Development
Table 124. ProteoGenex Company Details
Table 125. ProteoGenex Business Overview
Table 126. ProteoGenex Immortalized Human Cells Product
Table 127. ProteoGenex Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 128. ProteoGenex Recent Development
Table 129. CGT Global Company Details
Table 130. CGT Global Business Overview
Table 131. CGT Global Immortalized Human Cells Product
Table 132. CGT Global Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 133. CGT Global Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 137. Authors List of This Report
List of Figures
Figure 1. Immortalized Human Cells Picture
Figure 2. Global Immortalized Human Cells Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Immortalized Human Cells Market Share by Type: 2025 vs 2032
Figure 4. Ready-to-use Features
Figure 5. Customized Features
Figure 6. Global Immortalized Human Cells Market Size Comparison by Source (US$ Million), 2021–2032
Figure 7. Liver-Derived Features
Figure 8. Kidney-Derived Features
Figure 9. Nervous System-Derived Features
Figure 10. Other Features
Figure 11. Global Immortalized Human Cells Market Size Comparison by Identity (US$ Million), 2021–2032
Figure 12. Identified Samples Features
Figure 13. Anonymized Samples Features
Figure 14. Global Immortalized Human Cells Market Size by Application (US$ Million), 2021–2032
Figure 15. Global Immortalized Human Cells Market Share by Application: 2025 vs 2032
Figure 16. Medical Research Case Studies
Figure 17. Vaccine Development Case Studies
Figure 18. Gene Therapy Case Studies
Figure 19. Other Case Studies
Figure 20. Immortalized Human Cells Report Years Considered
Figure 21. Global Immortalized Human Cells Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 22. Global Immortalized Human Cells Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Immortalized Human Cells Market Share by Region: 2025 vs 2032
Figure 24. Global Immortalized Human Cells Market Share by Players in 2025
Figure 25. Global Immortalized Human Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by Immortalized Human Cells Revenue in 2025
Figure 27. North America Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. North America Immortalized Human Cells Market Share by Country (2021–2032)
Figure 29. United States Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Canada Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe Immortalized Human Cells Market Share by Country (2021–2032)
Figure 33. Germany Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. France Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. U.K. Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Italy Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Russia Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Ireland Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific Immortalized Human Cells Market Share by Region (2021–2032)
Figure 41. China Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Japan Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. South Korea Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Southeast Asia Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. India Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Australia & New Zealand Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America Immortalized Human Cells Market Share by Country (2021–2032)
Figure 49. Mexico Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Brazil Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa Immortalized Human Cells Market Share by Country (2021–2032)
Figure 53. Israel Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Saudi Arabia Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. UAE Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Ispecimen Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 57. ABO Bio Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 58. AnaBios Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 59. Biomedica Cro Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 60. Bioivt Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 61. Iprocess Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 62. Crown Bioscience Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 63. Biomex Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 64. PrecisionMed Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 65. Cureline Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 66. DX Biosamples Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 67. Audubon Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 68. Precision for Medicine Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 69. Discovery Life Sciences Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 70. ProteoGenex Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 71. CGT Global Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Table 1. Global Immortalized Human Cells Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Ready-to-use
Table 3. Key Players of Customized
Table 4. Global Immortalized Human Cells Market Size Growth Rate by Source (US$ Million): 2021 vs 2025 vs 2032
Table 5. Key Players of Liver-Derived
Table 6. Key Players of Kidney-Derived
Table 7. Key Players of Nervous System-Derived
Table 8. Key Players of Other
Table 9. Global Immortalized Human Cells Market Size Growth Rate by Identity (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Identified Samples
Table 11. Key Players of Anonymized Samples
Table 12. Global Immortalized Human Cells Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 13. Global Immortalized Human Cells Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 14. Global Immortalized Human Cells Market Size by Region (US$ Million), 2021–2026
Table 15. Global Immortalized Human Cells Market Share by Region (2021–2026)
Table 16. Global Immortalized Human Cells Forecasted Market Size by Region (US$ Million), 2027–2032
Table 17. Global Immortalized Human Cells Market Share by Region (2027–2032)
Table 18. Immortalized Human Cells Market Trends
Table 19. Immortalized Human Cells Market Drivers
Table 20. Immortalized Human Cells Market Challenges
Table 21. Immortalized Human Cells Market Restraints
Table 22. Global Immortalized Human Cells Revenue by Players (US$ Million), 2021–2026
Table 23. Global Immortalized Human Cells Market Share by Players (2021–2026)
Table 24. Global Top Immortalized Human Cells Players by Tier (Tier 1, Tier 2, and Tier 3), based on Immortalized Human Cells Revenue, 2025
Table 25. Ranking of Global Top Immortalized Human Cells Companies by Revenue (US$ Million) in 2025
Table 26. Global 5 Largest Players Market Share by Immortalized Human Cells Revenue (CR5 and HHI), 2021–2026
Table 27. Global Key Players of Immortalized Human Cells, Headquarters and Area Served
Table 28. Global Key Players of Immortalized Human Cells, Products and Applications
Table 29. Global Key Players of Immortalized Human Cells, Date of General Availability (GA)
Table 30. Mergers and Acquisitions, Expansion Plans
Table 31. Global Immortalized Human Cells Market Size by Type (US$ Million), 2021–2026
Table 32. Global Immortalized Human Cells Revenue Market Share by Type (2021–2026)
Table 33. Global Immortalized Human Cells Forecasted Market Size by Type (US$ Million), 2027–2032
Table 34. Global Immortalized Human Cells Revenue Market Share by Type (2027–2032)
Table 35. Global Immortalized Human Cells Market Size by Application (US$ Million), 2021–2026
Table 36. Global Immortalized Human Cells Revenue Market Share by Application (2021–2026)
Table 37. Global Immortalized Human Cells Forecasted Market Size by Application (US$ Million), 2027–2032
Table 38. Global Immortalized Human Cells Revenue Market Share by Application (2027–2032)
Table 39. North America Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 40. North America Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026
Table 41. North America Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032
Table 42. Europe Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 43. Europe Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026
Table 44. Europe Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032
Table 45. Asia-Pacific Immortalized Human Cells Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 46. Asia-Pacific Immortalized Human Cells Market Size by Region (US$ Million), 2021–2026
Table 47. Asia-Pacific Immortalized Human Cells Market Size by Region (US$ Million), 2027–2032
Table 48. Latin America Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Latin America Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026
Table 50. Latin America Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032
Table 51. Middle East & Africa Immortalized Human Cells Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 52. Middle East & Africa Immortalized Human Cells Market Size by Country (US$ Million), 2021–2026
Table 53. Middle East & Africa Immortalized Human Cells Market Size by Country (US$ Million), 2027–2032
Table 54. Ispecimen Company Details
Table 55. Ispecimen Business Overview
Table 56. Ispecimen Immortalized Human Cells Product
Table 57. Ispecimen Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 58. Ispecimen Recent Development
Table 59. ABO Bio Company Details
Table 60. ABO Bio Business Overview
Table 61. ABO Bio Immortalized Human Cells Product
Table 62. ABO Bio Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 63. ABO Bio Recent Development
Table 64. AnaBios Company Details
Table 65. AnaBios Business Overview
Table 66. AnaBios Immortalized Human Cells Product
Table 67. AnaBios Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 68. AnaBios Recent Development
Table 69. Biomedica Cro Company Details
Table 70. Biomedica Cro Business Overview
Table 71. Biomedica Cro Immortalized Human Cells Product
Table 72. Biomedica Cro Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 73. Biomedica Cro Recent Development
Table 74. Bioivt Company Details
Table 75. Bioivt Business Overview
Table 76. Bioivt Immortalized Human Cells Product
Table 77. Bioivt Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 78. Bioivt Recent Development
Table 79. Iprocess Company Details
Table 80. Iprocess Business Overview
Table 81. Iprocess Immortalized Human Cells Product
Table 82. Iprocess Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 83. Iprocess Recent Development
Table 84. Crown Bioscience Company Details
Table 85. Crown Bioscience Business Overview
Table 86. Crown Bioscience Immortalized Human Cells Product
Table 87. Crown Bioscience Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 88. Crown Bioscience Recent Development
Table 89. Biomex Company Details
Table 90. Biomex Business Overview
Table 91. Biomex Immortalized Human Cells Product
Table 92. Biomex Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 93. Biomex Recent Development
Table 94. PrecisionMed Company Details
Table 95. PrecisionMed Business Overview
Table 96. PrecisionMed Immortalized Human Cells Product
Table 97. PrecisionMed Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 98. PrecisionMed Recent Development
Table 99. Cureline Company Details
Table 100. Cureline Business Overview
Table 101. Cureline Immortalized Human Cells Product
Table 102. Cureline Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 103. Cureline Recent Development
Table 104. DX Biosamples Company Details
Table 105. DX Biosamples Business Overview
Table 106. DX Biosamples Immortalized Human Cells Product
Table 107. DX Biosamples Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 108. DX Biosamples Recent Development
Table 109. Audubon Company Details
Table 110. Audubon Business Overview
Table 111. Audubon Immortalized Human Cells Product
Table 112. Audubon Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 113. Audubon Recent Development
Table 114. Precision for Medicine Company Details
Table 115. Precision for Medicine Business Overview
Table 116. Precision for Medicine Immortalized Human Cells Product
Table 117. Precision for Medicine Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 118. Precision for Medicine Recent Development
Table 119. Discovery Life Sciences Company Details
Table 120. Discovery Life Sciences Business Overview
Table 121. Discovery Life Sciences Immortalized Human Cells Product
Table 122. Discovery Life Sciences Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 123. Discovery Life Sciences Recent Development
Table 124. ProteoGenex Company Details
Table 125. ProteoGenex Business Overview
Table 126. ProteoGenex Immortalized Human Cells Product
Table 127. ProteoGenex Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 128. ProteoGenex Recent Development
Table 129. CGT Global Company Details
Table 130. CGT Global Business Overview
Table 131. CGT Global Immortalized Human Cells Product
Table 132. CGT Global Revenue in Immortalized Human Cells Business (US$ Million), 2021–2026
Table 133. CGT Global Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
Table 137. Authors List of This Report
List of Figures
Figure 1. Immortalized Human Cells Picture
Figure 2. Global Immortalized Human Cells Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Immortalized Human Cells Market Share by Type: 2025 vs 2032
Figure 4. Ready-to-use Features
Figure 5. Customized Features
Figure 6. Global Immortalized Human Cells Market Size Comparison by Source (US$ Million), 2021–2032
Figure 7. Liver-Derived Features
Figure 8. Kidney-Derived Features
Figure 9. Nervous System-Derived Features
Figure 10. Other Features
Figure 11. Global Immortalized Human Cells Market Size Comparison by Identity (US$ Million), 2021–2032
Figure 12. Identified Samples Features
Figure 13. Anonymized Samples Features
Figure 14. Global Immortalized Human Cells Market Size by Application (US$ Million), 2021–2032
Figure 15. Global Immortalized Human Cells Market Share by Application: 2025 vs 2032
Figure 16. Medical Research Case Studies
Figure 17. Vaccine Development Case Studies
Figure 18. Gene Therapy Case Studies
Figure 19. Other Case Studies
Figure 20. Immortalized Human Cells Report Years Considered
Figure 21. Global Immortalized Human Cells Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 22. Global Immortalized Human Cells Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Immortalized Human Cells Market Share by Region: 2025 vs 2032
Figure 24. Global Immortalized Human Cells Market Share by Players in 2025
Figure 25. Global Immortalized Human Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 26. The Top 10 and 5 Players Market Share by Immortalized Human Cells Revenue in 2025
Figure 27. North America Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. North America Immortalized Human Cells Market Share by Country (2021–2032)
Figure 29. United States Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Canada Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Europe Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Europe Immortalized Human Cells Market Share by Country (2021–2032)
Figure 33. Germany Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. France Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. U.K. Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Italy Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Russia Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Ireland Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Asia-Pacific Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Asia-Pacific Immortalized Human Cells Market Share by Region (2021–2032)
Figure 41. China Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Japan Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. South Korea Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Southeast Asia Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. India Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Australia & New Zealand Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Latin America Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Latin America Immortalized Human Cells Market Share by Country (2021–2032)
Figure 49. Mexico Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Brazil Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Middle East & Africa Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Middle East & Africa Immortalized Human Cells Market Share by Country (2021–2032)
Figure 53. Israel Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Saudi Arabia Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. UAE Immortalized Human Cells Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Ispecimen Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 57. ABO Bio Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 58. AnaBios Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 59. Biomedica Cro Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 60. Bioivt Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 61. Iprocess Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 62. Crown Bioscience Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 63. Biomex Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 64. PrecisionMed Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 65. Cureline Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 66. DX Biosamples Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 67. Audubon Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 68. Precision for Medicine Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 69. Discovery Life Sciences Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 70. ProteoGenex Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 71. CGT Global Revenue Growth Rate in Immortalized Human Cells Business (2021–2026)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232